| L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity R Geiger, JC Rieckmann, T Wolf, C Basso, Y Feng, T Fuhrer, ... Cell 167 (3), 829-842. e13, 2016 | 1335 | 2016 |
| Mapping human microbiome drug metabolism by gut bacteria and their genes M Zimmermann, M Zimmermann-Kogadeeva, R Wegmann, AL Goodman Nature 570 (7762), 462-467, 2019 | 804 | 2019 |
| Separating host and microbiome contributions to drug pharmacokinetics and toxicity M Zimmermann, M Zimmermann-Kogadeeva, R Wegmann, AL Goodman Science 363 (6427), eaat9931, 2019 | 324 | 2019 |
| Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis OT Schubert, C Ludwig, M Kogadeeva, M Zimmermann, G Rosenberger, ... Cell host & microbe 18 (1), 96-108, 2015 | 220 | 2015 |
| Regulation of yeast central metabolism by enzyme phosphorylation AP Oliveira, C Ludwig, P Picotti, M Kogadeeva, R Aebersold, U Sauer Molecular Systems Biology 8 (1), 623, 2012 | 193 | 2012 |
| High coverage metabolomics analysis reveals phage-specific alterations to Pseudomonas aeruginosa physiology during infection J De Smet, M Zimmermann, M Kogadeeva, PJ Ceyssens, W Vermaelen, ... The ISME journal 10 (8), 1823-1835, 2016 | 142 | 2016 |
| Combinatorial, additive and dose-dependent drug–microbiome associations SK Forslund, R Chakaroun, M Zimmermann-Kogadeeva, L Markó, ... Nature 600 (7889), 500-505, 2021 | 118 | 2021 |
| Next-Generation “-omics” Approaches Reveal a Massive Alteration of Host RNA Metabolism during Bacteriophage Infection of Pseudomonas aeruginosa A Chevallereau, BG Blasdel, J De Smet, M Monot, M Zimmermann, ... PLoS genetics 12 (7), e1006134, 2016 | 112 | 2016 |
| Microbiome and metabolome features of the cardiometabolic disease spectrum S Fromentin, SK Forslund, K Chechi, J Aron-Wisnewsky, R Chakaroun, ... Nature medicine 28 (2), 303-314, 2022 | 108 | 2022 |
| Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota AE Lindell, M Zimmermann-Kogadeeva, KR Patil Nature Reviews Microbiology 20 (7), 431-443, 2022 | 101 | 2022 |
| Integration of metabolomics and transcriptomics reveals a complex diet of Mycobacterium tuberculosis during early macrophage infection M Zimmermann, M Kogadeeva, M Gengenbacher, G McEwen, ... MSystems 2 (4), 10.1128/msystems. 00057-17, 2017 | 97 | 2017 |
| Visualizing translation dynamics at atomic detail inside a bacterial cell L Xue, S Lenz, M Zimmermann-Kogadeeva, D Tegunov, P Cramer, P Bork, ... Nature 610 (7930), 205-211, 2022 | 73 | 2022 |
| The Stringent Response Determines the Ability of a Commensal Bacterium to Survive Starvation and to Persist in the Gut WB Schofield, M Zimmermann-Kogadeeva, M Zimmermann, NA Barry, ... Cell host & microbe 24 (1), 120-132. e6, 2018 | 61 | 2018 |
| SUMOFLUX: A Generalized Method for Targeted 13C Metabolic Flux Ratio Analysis M Kogadeeva, N Zamboni PLoS computational biology 12 (9), e1005109, 2016 | 44 | 2016 |
| Insights from pharmacokinetic models of host-microbiome drug metabolism M Zimmermann-Kogadeeva, M Zimmermann, AL Goodman Gut microbes 11 (3), 587-596, 2020 | 30 | 2020 |
| Metabolic reprogramming of Pseudomonas aeruginosa by phage-based quorum sensing modulation H Hendrix, M Zimmermann-Kogadeeva, M Zimmermann, U Sauer, ... Cell Reports 38 (7), 110372, 2022 | 23 | 2022 |
| Recent advances in data-and knowledge-driven approaches to explore primary microbial metabolism BJ Bartmanski, M Rocha, M Zimmermann-Kogadeeva Current Opinion in Chemical Biology 75, 102324, 2023 | 3 | 2023 |
| Quantifying host-microbiota interactions M Zimmermann-Kogadeeva Science 373 (6551), 173-173, 2021 | 3 | 2021 |
| Consistency across multi‐omics layers in a drug‐perturbed gut microbial community S Wuyts, R Alves, M Zimmermann‐Kogadeeva, S Nishijima, S Blasche, ... Molecular Systems Biology 19 (9), e11525, 2023 | 2 | 2023 |
| AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications J Notter, SN Seiffert, M Zimmermann-Kogadeeva, A Bösch, R Wenger, ... BMC Infectious Diseases 22 (1), 33, 2022 | 2 | 2022 |
Michael ZimmermannGroup Leader, EMBLVerified email at embl.de
